These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 35057816)

  • 1. The empirical support for the radical cure strategy for eliminating Plasmodium vivax in China.
    Yang GJ; Shang LY; Zhou XN; Lee TE; Bi B; White M; Smith TA; Penny MA
    BMC Med; 2022 Jan; 20(1):17. PubMed ID: 35057816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypnozoite dynamics for Plasmodium vivax malaria: The epidemiological effects of radical cure.
    Mehra S; Stadler E; Khoury D; McCaw JM; Flegg JA
    J Theor Biol; 2022 Mar; 537():111014. PubMed ID: 35016895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse.
    White NJ; Imwong M
    Adv Parasitol; 2012; 80():113-50. PubMed ID: 23199487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Plasmodium vivax outbreak to elimination: lessons learnt from a retrospective analysis of data from Guantang.
    Yang GJ; Liu Y; Shang LY; Zhang HW; Zhou XN; Penny MA; Smith TA
    Malar J; 2020 Nov; 19(1):427. PubMed ID: 33228679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal Interruption of P. vivax Malaria Transmission Using Mass Drug Administration.
    Anwar MN; Hickson RI; Mehra S; Price DJ; McCaw JM; Flegg MB; Flegg JA
    Bull Math Biol; 2023 Apr; 85(6):43. PubMed ID: 37076740
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Schäfer C; Zanghi G; Vaughan AM; Kappe SHI
    Annu Rev Microbiol; 2021 Oct; 75():87-106. PubMed ID: 34196569
    [No Abstract]   [Full Text] [Related]  

  • 7. Determinants of relapse periodicity in Plasmodium vivax malaria.
    White NJ
    Malar J; 2011 Oct; 10():297. PubMed ID: 21989376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model.
    Robinson LJ; Wampfler R; Betuela I; Karl S; White MT; Li Wai Suen CS; Hofmann NE; Kinboro B; Waltmann A; Brewster J; Lorry L; Tarongka N; Samol L; Silkey M; Bassat Q; Siba PM; Schofield L; Felger I; Mueller I
    PLoS Med; 2015 Oct; 12(10):e1001891. PubMed ID: 26505753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of malaria due to Plasmodium vivax in central part of the People's Republic of China: analysis and prediction based on modelling.
    Chen Z; Shi L; Zhou XN; Xia ZG; Bergquist R; Jiang QW
    Geospat Health; 2014 Nov; 9(1):169-77. PubMed ID: 25545934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of primaquine in malaria control and elimination in French-speaking Africa].
    Briolant S; Pradines B; Basco LK
    Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax.
    Campo B; Vandal O; Wesche DL; Burrows JN
    Pathog Glob Health; 2015 May; 109(3):107-22. PubMed ID: 25891812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of P. vivax elimination via mass drug administration: A simulation study.
    Anwar MN; McCaw JM; Zarebski AE; Hickson RI; Flegg JA
    Epidemics; 2024 Sep; 48():100789. PubMed ID: 39255654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium vivax Relapse Rates in Allied Soldiers during the Second World War: Importance of Hypnozoite Burden.
    Shanks GD
    Am J Trop Med Hyg; 2022 Dec; 107(6):1173-1177. PubMed ID: 36343595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying effect of geographic location on epidemiology of Plasmodium vivax malaria.
    Lover AA; Coker RJ
    Emerg Infect Dis; 2013 Jul; 19(7):1058-65. PubMed ID: 23763820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium vivax malaria: a re-emerging threat for temperate climate zones?
    Petersen E; Severini C; Picot S
    Travel Med Infect Dis; 2013; 11(1):51-9. PubMed ID: 23498971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission.
    White MT; Karl S; Battle KE; Hay SI; Mueller I; Ghani AC
    Elife; 2014 Nov; 3():. PubMed ID: 25406065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the hypnozoite: a part of Plasmodium vivax life cycle and survival.
    Hulden L; Hulden L
    Malar J; 2011 Apr; 10():90. PubMed ID: 21496287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of Plasmodium vivax populations in border areas of the Greater Mekong sub-region during malaria elimination.
    Li Y; Hu Y; Zhao Y; Wang Q; Ngassa Mbenda HG; Kittichai V; Lawpoolsri S; Sattabongkot J; Menezes L; Liu X; Cui L; Cao Y
    Malar J; 2020 Apr; 19(1):145. PubMed ID: 32268906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model for malaria treatment evaluation in the presence of multiple species.
    Walker CR; Hickson RI; Chang E; Ngor P; Sovannaroth S; Simpson JA; Price DJ; McCaw JM; Price RN; Flegg JA; Devine A
    Epidemics; 2023 Sep; 44():100687. PubMed ID: 37348379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intervention portfolios analysis of Plasmodium vivax control in central China.
    Bi B; Wu L; Liu Y; Zhou XN; Shen T; Cao L; White M; Yang GJ
    Malar J; 2024 Aug; 23(1):242. PubMed ID: 39138510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.